4//SEC Filing
Spada Alfred P. 4
Accession 0000899243-20-014290
CIK 0001383701other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:05 AM ET
Size
10.1 KB
Accession
0000899243-20-014290
Insider Transaction Report
Form 4
Histogen Inc.HSTO
Spada Alfred P.
SVP, R&D and CSO
Transactions
- Exercise/Conversion
Common Stock
2020-05-22+31,343→ 32,555 total - Tax Payment
Common Stock
2020-05-22$0.56/sh−12,960$7,258→ 19,595 total - Exercise/Conversion
Restricted Stock Units
2020-05-22−31,343→ 0 total→ Common Stock (31,343 underlying)
Holdings
- 24,714(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Held by a family trust of which Dr. Spada is a trustee.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]Pursuant to the Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among Conatus Pharmaceuticals Inc. ("Conatus"), Chinook Merger Sub, Inc. and Histogen Inc., all outstanding Conatus restricted stock units vested in full and were settled in shares of common stock prior to the closing of the merger contemplated by the Merger Agreement.
Documents
Issuer
Histogen Inc.
CIK 0001383701
Entity typeother
Related Parties
1- filerCIK 0001580465
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 6:05 AM ET
- Size
- 10.1 KB